Not Approved

After inspection, the State Food and Drug Administration has not approved the drug named "Guifeishua Nursing Sheet" (result returned by the State Drug Administration). "Guifeishua Sheath" is not a medicine and cannot replace medicines to treat diseases. Consumers are advised to choose carefully. It is recommended that consumers choose regular drugs for treating diseases and look for the "National Drug Approval" when buying drugs.

Drug Price 315 Network reminds you: Some websites describe "Guifeishua Care Sheet" as "Guifeishua, the product has the effects of regulating the vagina, anti-inflammatory and sterilizing, removing putrefaction and promoting muscle growth. It can regulate various "Gynecological diseases such as vaginitis, cervicitis, endometritis, adnexitis, pelvic inflammatory disease, etc. "Using Guifei Sihua can regulate the vagina, cleanse the uterus, detoxify, and remove freckles and acne." A large number of medical terms are used to claim or imply treatment. Disease, suspected of illegal advertising and false propaganda to deceive consumers, consumers are advised not to believe it.

After investigation, "Guifei Sihua" is a registered trademark of Jiangsu Tianfukang Biotechnology Co., Ltd., and its trademark information is as follows:

Application/registration number: 30213161

Application date: April 12, 2018

International classification: 5

Applicant name (Chinese): Jiangsu Tianfukang Biotechnology Co., Ltd.

Applicant address (Chinese): No. 1858, Zhencheng Road, Jiangyin City, Wuxi City, Jiangsu Province

Goods/Services: Medicinal beverages; Disinfectants; Medical drugs; Traditional Chinese medicines; Purifiers; Animal meals Supplements; Fungicides; Dietary fiber; Sanitary disinfectants; Medical mouthwashes.

The need for medication is closely related to everyone. The newly revised "Drug Administration Law" was officially implemented on December 1, 2019. Compared with the old version, it will no longer classify drugs that have not been produced, imported, or inspected without approval. Drugs are defined as counterfeit drugs. This is also one of the important reasons for the change in the characterization of the charges in the retrial of this case. In the first instance, the defendant was convicted of selling counterfeit medicines, but in this retrial, it was changed to the crime of smuggling goods prohibited from import and export by the country, which reflects that the bottom line of the law cannot be touched. At the same time, lawyers said that unapproved imported genuine drugs will no longer be identified as "fake drugs", which is more in line with public perception.

The old "Drug Administration Law of the People's Republic of China" stipulates that any of the following conditions will become counterfeit drugs: Counterfeit drugs refer to drugs whose ingredients are inconsistent with those specified in national drug standards. Or a non-drug is passed off as a drug or other drugs are passed off as this kind of drug. The six situations in which drugs are treated as counterfeit include: ① Use prohibited by the drug regulatory department of the State Council;

② Production or import without approval when approval is required in accordance with this law, or inspection is not required in accordance with this law. Sold immediately after inspection;

③ Deteriorated;

④ Contaminated; Produced by APIs with registration number; ⑥The indicated indications or functional indications exceed the prescribed scope.